Membrane-confined self-assembly enables localized bioorthogonal prodrug activation and selective cancer therapy
Bioorthogonal prodrug activation offers a promising approach for site-specific drug release, significantly reducing the systemic toxicity associated with conventional chemotherapy. However, challenges remain in precisely controlling prodrug activation at ...